Skip to content

ELEKTA

Active Public limited companyfounded 1997active for 29 yearsBelgicastraat 11, 1930 ZaventemKBO/BCE: BE 0460.510.369 subsidiary of

Lifetime

21 annual accounts with figures on one time axis, 29 filings since 1998
peak of €27.0m in 2022
€13.9m▲ 13.5%
peak of €1.5m in 2021
€753,993▼ 13.1%
peak of €6.5m in 2022
€2.7m▼ 31.2%
€10.3m▼ 4.8%
peak of 15.7 FTE in 2023
12.2 FTE▼ 11.6%
Board3 names since 2016
2 directors and 1 other
Owners3 names in the annual accounts
99.6% and 1 other
Documentsfilings and deeds
23-09-202668 days before the deadline
2026financial year
Turnover from €12.3m to €13.9mStaff from 13.8 FTE to 12.2 FTE resigns as director 23-06 (director) and (statutory auditor) reappointed 09-02Dividend €2.0mEquity from €4.0m to €2.7m

Key points

from the 2026 annual accounts

Equity

€2.7m ▼ 31.2%
4.02025+0.8Profit-2.0Dividend2.72026

ELEKTA paid out €2.0m in dividends. That is 265% of the 2026 profit.

Debts

€10.3m 79% of the balance sheet
Suppliers 17%Taxes and wages 5%Other 78%

Of this, €6.5m falls due within a year.

Investments

€1,993 0.0 times depreciation
2022202320242026

Green is investment, beige is depreciation.

Staff

12 employees on 30-04-2026
312022112023012024022025122026

In 2026, 1 employee joined and 2 left.

Payment terms

62 days to suppliers
Suppliers
59 to 62
Customers
75 to 154

ELEKTA pays its suppliers 3 days later than in 2025. Customers pay 79 days later.

Filings

29 annual accounts since 1998
deadline200020102020

Seven of the last ten came late. The 2022 accounts came in latest, 253 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,615 companies had the same profile as ELEKTA has now. Each dot stands for 7 companies, two years later.

97.3%
were still trading
2.0%
stopped another way
0.7%
went bankrupt
  • Small
  • 20 years or older
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,615 companies, not a prediction for ELEKTA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director, since 30-04-2026
Auditor,
  • 99.6%annual accounts 30-04-2026
  • 0.4%annual accounts 30-04-2026
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0460510369
resigns as director appointed as director · General meeting of 19-05-2026 · Gazette deed
(director) and (statutory auditor) reappointed General meeting of 04-12-2025 · Gazette deed
reappointed as statutory auditor General meeting of 15-06-2023 · Gazette deed
All 60 events

Comparable companies

same main activity, similar in size and age
Company
ELEKTA Zaventem €13.9m 8.0% 21.0% 12.2
MEDICOR MEDICAL SUPPLIES Rotselaar €18.5m 8.7% 84.1% 14.3
EMDOKA Hoogstraten €17.3m 21.6% 78.3% 14.1
ALEAMED Kontich €15.9m 0.5% 4.4% 9.8
DE CEUNYNCK MEDICAL Aartselaar €14.4m 2.1% 84.3% 21.3
BeMedico Herzele €17.4m 8.1% 66.2% 14.6
Abbott Rapid Diagnostics Zaventem €7.9m 3.7% 89.1% 7.9
-10%0%10%20%€10m€100m€1bn€10bnELEKTAEBIT margin

Grey: the largest companies of the sector (wholesale trade (NACE 46)), without their names. Blue: the sector peers from the table.

These companies have the same main activity as ELEKTA: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €7.1m and €17m, founded between 1987 and 1999.

Official details

Source: KBO
Status
Active since 17-04-1997Normal situation
Registered office
11 active companies are registered at this addressOf these, 1 started in the 12 months before 21 November 2026. Source: KBO register, as of 21 November 2026.
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Joint committee
200Auxiliary committee for white-collar workers · annual accounts 30-04-2026
Establishment unit
2.081.911.1961930 Zaventem, since 22-05-1997
Financial year end
30 April
Peppol
Reachable since 04-09-2026
Company details

Annual accounts to 30-04-2026

€13.1m▼ 11.9%
Employeeson 30-04-2026
12▼ 7.7%
Filing
Filed on 23-09-2026, 68 days before the end of the filing period
Financials

Insights on ELEKTA

ELEKTA has existed since 1997. Turnover grew from €4.9m in 2002 to €13.9m in 2026 and staff from 7.4 to 12.2 full-time equivalents.

Solvency fell in 2026 from 26.9% to 21.0% because of the dividend.

holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about ELEKTA

What is the company number of ELEKTA?
The company number of ELEKTA is 0460.510.369. The VAT number is the same number with BE in front: BE 0460.510.369.
Where is ELEKTA based?
The registered office is at Belgicastraat 11, 1930 Zaventem.Company details
What does ELEKTA do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of ELEKTA?
ELEKTA is a public limited company (NV).
When was ELEKTA founded?
ELEKTA was founded on 17-04-1997.
Is ELEKTA still active?
Yes, ELEKTA is an active enterprise in the KBO register.
How many employees does ELEKTA have?
ELEKTA had an average of 12.2 full-time equivalents in financial year 2026, according to the filed annual accounts.Financials
Which joint committee does ELEKTA fall under?
In its 30-04-2026 annual accounts, ELEKTA states joint committee 200 (Auxiliary committee for white-collar workers).
What is the turnover of ELEKTA?
The turnover of ELEKTA was €13.9m in financial year 2026, according to the filed annual accounts.
Is ELEKTA profitable?
In financial year 2026, ELEKTA made a profit of €753,993.
Where can I find the annual accounts of ELEKTA?
ELEKTA filed 29 annual accounts with the National Bank of Belgium, the latest for financial year 2026.
When are the next annual accounts of ELEKTA due?
ELEKTA must file the annual accounts for financial year 2027 by 30-11-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.